MMC vs NMRA · P/E 22, rev $26.98B vs $283.5M cap
Marsh & McLennan Companies Inc (MMC) versus Neumora Therapeutics, Inc. (NMRA) — a side-by-side from cached financials, not a winner call.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Latest reported MMC revenue for 2025-12-31 was $26.98B. Net income was $4.16B. Revenue was up 10.3% from 2024-12-31 to 2025-12-31. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
NMRA does not have a complete income-statement cache yet.
MMC currently screens at market cap $89.82B and trailing P/E 21.9. NMRA currently screens at market cap $283.5M.
Not investment advice. Open the MMC and NMRA stock pages for the full models.
Not investment advice.